Iron Deficiency and the Risk of Incident Left Ventricular Dysfunction in Patients with Coronary Artery Disease: A Single-center Cohort Study

Abstract Background: Heart failure (HF) is a complex and life-threatening condition that often coexists with comorbidities such as hypertension, type 2 diabetes mellitus, coronary artery disease (CAD), and iron deficiency (ID). However, the relationship between ID and the development of HF remains poorly understood. Aim: This study aimed to investigate the correlation between ID and the development of left ventricular dysfunction. Methods: A total of 64,661 patients diagnosed with CAD at a tertiary hospital between 2011 and 2023 were recruited. Of these, 4813 patients who underwent iron status evaluation, including serum iron (SI), total iron-binding capacity (TIBC), and ferritin within 30 days, were included in the analysis. We compared the incidence and hazard ratio (HR) of new-onset left ventricular (LV) dysfunction (LV ejection fraction <50%) between patients with and without ID, defined as SI/TIBC or transferrin saturation (TSAT) <20% or ferritin <100 ng/mL. Results: The incidence of new-onset LV dysfunction was higher in patients with ID, defined by TSAT <20% compared to those with normal TSAT (HR, 1.40; 95% confidence interval [CI], 1.14–1.72) over a 13-year follow-up. In multivariable analysis, TSAT <20% retained its predictive value for new-onset LV dysfunction (adjusted HR, 1.24; 95% CI, 1.01–1.54), while ferritin levels were not correlated with the incidence of new-onset LV dysfunction in this cohort. The all-cause mortality rate was also higher in patients with ID, defined by TSAT <20% compared to those with normal TSAT. A subgroup analysis revealed no significant difference in predicting new-onset LV dysfunction between patients with ID, with or without coexisting anemia ( P = 0.165). Conclusion: In patients with CAD, ID, particularly defined by TSAT <20%, was predictive of future LV dysfunction and associated outcomes. Further studies are needed to investigate the underlying mechanisms and causal relationship between ID and the risk of LV dysfunction.

Authors

Institutions

Publication Details

Journal
Journal of Medical Sciences
Published
2025-05-01
DOI
https://doi.org/10.4103/jmedsci.jmedsci_12_25
Primary Topic
Erythropoietin and Anemia Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Iron Deficiency and the Risk of Incident Left Ventricular Dysfunction in Patients with Coronary Artery Disease: A Single-center Cohort Study

Yu‐Lan Liu, Shi-Chue Hsing, Hsin-Hui Chen, Chiao‐Chin Lee et al.
1 links
Journal of Medical Sciences
Erythropoietin and Anemia Treatment
article

Iron Deficiency and the Risk of Incident Left Ventricular Dysfunction in Patients with Coronary Artery Disease: A Single-center Cohort Study

Yu‐Lan Liu, Shi-Chue Hsing, Hsin-Hui Chen, Chiao‐Chin Lee, Chiao‐Hsiang Chang, Wei-Ting Liu
article en

Abstract

Abstract Background: Heart failure (HF) is a complex and life-threatening condition that often coexists with comorbidities such as hypertension, type 2 diabetes mellitus, coronary artery disease (CAD), and iron deficiency (ID). However, the relationship between ID and the development of HF remains poorly understood. Aim: This study aimed to investigate the correlation between ID and the development of left ventricular dysfunction. Methods: A total of 64,661 patients diagnosed with CAD at a tertiary hospital between 2011 and 2023 were recruited. Of these, 4813 patients who underwent iron status evaluation, including serum iron (SI), total iron-binding capacity (TIBC), and ferritin within 30 days, were included in the analysis. We compared the incidence and hazard ratio (HR) of new-onset left ventricular (LV) dysfunction (LV ejection fraction <50%) between patients with and without ID, defined as SI/TIBC or transferrin saturation (TSAT) <20% or ferritin <100 ng/mL. Results: The incidence of new-onset LV dysfunction was higher in patients with ID, defined by TSAT <20% compared to those with normal TSAT (HR, 1.40; 95% confidence interval [CI], 1.14–1.72) over a 13-year follow-up. In multivariable analysis, TSAT <20% retained its predictive value for new-onset LV dysfunction (adjusted HR, 1.24; 95% CI, 1.01–1.54), while ferritin levels were not correlated with the incidence of new-onset LV dysfunction in this cohort. The all-cause mortality rate was also higher in patients with ID, defined by TSAT <20% compared to those with normal TSAT. A subgroup analysis revealed no significant difference in predicting new-onset LV dysfunction between patients with ID, with or without coexisting anemia ( P = 0.165). Conclusion: In patients with CAD, ID, particularly defined by TSAT <20%, was predictive of future LV dysfunction and associated outcomes. Further studies are needed to investigate the underlying mechanisms and causal relationship between ID and the risk of LV dysfunction.

Journal of Medical SciencesVol. 45(3)
Tri-Service General Hospital (TW), National Defense Medical Center (TW)
Openalex Percentile: Top 85%
Erythropoietin and Anemia Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.